ICICI Prudential MNC Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 27-09-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities within MNC space.However there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
NIFTY MNC - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI MAGNUM GLOBAL FUND - REGULAR PLAN -GROWTH Sep 30, 1994 17.48 22.17 15.23 1.89 6,272.50
Aditya Birla Sun Life MNC Fund - Growth - Regular Plan Dec 27, 1999 14.18 12.15 8.07 2.01 3,461.59
UTI - MNC Fund - Regular Plan - Growth Option Oct 14, 1998 14.46 16.88 10.01 2.03 2,610.32

Fund Holdings as on 31-August-2023

  • Maruti Suzuki India Ltd.

  • TREPS

  • Sun Pharmaceutical Industries Ltd.

  • Hindustan Unilever Ltd.

  • Infosys Ltd.

  • Bharti Airtel Ltd.

  • Larsen & Toubro Ltd.

  • Siemens Ltd.

  • Dabur India Ltd.

  • Procter & Gamble Hygiene and Health Care Ltd.

  • Bata India Ltd.

  • EPL Ltd.

  • Zee Entertainment Enterprises Ltd.

  • Biocon Ltd.

  • Tata Motors Ltd. - DVR

  • Gland Pharma Ltd.

  • Lupin Ltd.

  • Nestle India Ltd.

  • Ashok Leyland Ltd.

  • FDC Ltd.

  • Glaxosmithkline Pharmaceuticals Ltd.

  • United Breweries Ltd.

  • Whirlpool of India Ltd.

  • Syngene International Ltd.

  • The Great Eastern Shipping Company Ltd.

  • Hitachi Energy India Ltd.

  • Viatris Inc.

  • SKF India Ltd.

  • Natco Pharma Ltd.

  • Schaeffler India Ltd.

  • Cognizant Tech Solutions

  • Timken India Ltd.

  • Route Mobile Ltd.

  • Ingersoll - Rand (India) Ltd

  • Tatva Chintan Pharma Chem Ltd.

  • GE T&D India Ltd.

  • HCL Technologies Ltd.

  • Tata Communications Ltd.

  • Kennametal India Ltd.

  • Indoco Remedies Ltd.

  • Endurance Technologies Pvt. Ltd.

  • Symphony Ltd

  • Mayur Uniquoters Ltd.

  • Gillette India Ltd.

  • BASF India Ltd.

  • CIE Automotive India Ltd

  • Net Current Assets

View More
  • Pharmaceuticals & Drugs

  • Household & Personal Products

  • Automobiles - Passenger Cars

  • Miscellaneous

  • IT - Software

  • Electric Equipment

  • Telecommunication - Service Provider

  • Engineering - Construction

  • Bearings

  • Retailing

  • Plastic Products

  • TV Broadcasting & Software Production

  • Consumer Durables - Domestic Appliances

  • Consumer Food

  • Automobiles-Trucks/Lcv

  • Breweries & Distilleries

  • Shipping

  • Compressors / Pumps

  • Chemicals

  • Engineering

  • Auto Ancillary

  • Textile

  • Pesticides & Agrochemicals

  • Forgings

View More

About ICICI Prudential MNC Fund

Scheme Analysis

ICICI Prudential MNC Fund is a Equity - Thematic Fund - MNC fund and belongs to ICICI Prudential Mutual Fund. It was launched on 17-Jun-2019 and currently has an AUM of ₹1,473.38 crore. ICICI Prudential MNC Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY MNC - TRI as secondary index.

The NAV of ICICI Prudential MNC Fund ended up ₹0.19(0.84%)yesterday to ₹22.84.

Among its top 3 holdings the fund has exposure to Maruti Suzuki India Ltd., and

The ICICI Prudential MNC Fund is managed by Roshan Chutkey .

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100